What is CE&IC?
Established in 1984, CE&IC operates as a premier full-service cGMP engineering and design firm. The organization provides critical infrastructure support to the life sciences industry, offering a comprehensive suite of services that includes project design, technical consulting, and multi-disciplinary engineering. By focusing on the development of compliant, efficient, and cost-effective facilities, CE&IC has become an essential partner for industry leaders looking to optimize their manufacturing processes. The firm's longevity and consistent project delivery have established it as a cornerstone of the pharmaceutical supply chain, ensuring that complex regulatory requirements are met with precision and technical rigor.
How much funding has CE&IC raised?
CE&IC has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in CE&IC
PPP
Public-Private Partnership
What's next for CE&IC?
With this late-stage capital, CE&IC is well-positioned to scale its operations and enhance its service offerings to meet the evolving demands of the global biotechnology landscape. The strategic deployment of these funds will likely focus on expanding the firm's engineering capacity and deepening its expertise in emerging manufacturing technologies. As the pharmaceutical industry continues to prioritize facility modernization and regulatory compliance, CE&IC is poised to leverage its historical success to capture additional market share. The firm's focus remains on maintaining long-term client relationships while driving innovation in facility design, ensuring that it remains at the forefront of industrial engineering excellence.
See full CE&IC company page
